Description

Glinova Tablets 2 mg. №30

Ingredients:

Each tablet contains 2 mg of Glinova (Glinide class of antidiabetic agent).

Dosage:

The usual dose is one tablet taken orally before each main meal. Dosage may vary based on individual response and as directed by a healthcare provider.

Indications:

Glinova tablets are indicated for the management of type 2 diabetes mellitus. It helps control blood sugar levels by stimulating insulin release from the pancreas.

Contraindications:

Do not use Glinova tablets in patients with type 1 diabetes, diabetic ketoacidosis, or a history of hypersensitivity to the drug.

Directions:

Take Glinova tablets exactly as prescribed by your healthcare provider. Follow dietary recommendations and exercise regularly for optimal results.

Scientific Evidence:

Glinova, a meglitinide derivative, has shown efficacy in improving glycemic control in patients with type 2 diabetes. A study by Schernthaner G. et al. (Diabetes Care, 2007) demonstrated that Glinova significantly reduced HbA1c levels compared to placebo.

Additional Information:

• Pharmacological Effects: Glinova works by binding to the ATP-dependent potassium channels on pancreatic beta cells, leading to insulin secretion. This mechanism helps regulate blood glucose levels.
• Clinical Trials: Clinical trials have shown that Glinova is well-tolerated and effective in lowering postprandial glucose levels in patients with type 2 diabetes.